Erratum for: Pharmacokinetic Evaluation of Visnagin and Ammi visnaga Aqueous Extract after Oral Administration in Rats
Published in Planta Medica 2012; 78 (17): 1831–1836
[Table 1] has been corrected.
Table 1 Results of non-compartmental analysis (median (SD)). VG: visnagin, AVE: Ammi visnaga extract, N: number of subjects, AUClast: AUC over the time interval from zero to last quantifiable time point, AUCinf: AUC over the time interval from zero extrapolated to infinity, Cmax: maximum observed concentration, tmax: time at Cmax, λz: terminal elimination rate constant, t1/2: terminal half-life, AUMClast: AUMC over the time interval from zero to last quantifiable time point, AUMCinf: AUMC over the time interval from zero extrapolated to infinity, MRTlast: mean residence time over the time interval from zero to last quantifiable time point, MRTinf: mean residence time over the time interval from zero extrapolated to infinity, CL/F: clearance uncorrected for oral bioavailability (F), Vz/F: volume of distribution during the terminal phase λz uncorrected for F.
Dosing Group (mg/kg)
|
2.5
|
5
|
10
|
Compound
|
VG
|
AVE
|
VG
|
AVE
|
VG
|
AVE
|
N
|
8
|
7
|
8
|
6
|
8
|
5
|
+ Plasma concentration-time profiles with an extrapolated AUC greater than 50 % were excluded from calculation for those parameters, N = 7, 7, 8, 6, 6, 5
++ Plasma concentration-time profiles with an extrapolated AUMC greater than 50 % were excluded from calculation for those parameters, N = 7, 7, 8, 6, 4, 5
|
AUClast (mg*h/L)
|
0.21 (0.29)
|
2.72 (0.65)
|
2.45 (2.40)
|
10.11 (2.66)
|
9.85 (4.09)
|
35.42 (11.59)
|
AUCinf (mg*h/L)+
|
0.15 (0.33)
|
2.72 (0.67)
|
2.45 (2.49)
|
10.22 (2.49)
|
10.14 (7.86)
|
35.67 (11.42)
|
AUC extrap. (%)+
|
0.10 (2.37)
|
0.08 (3.99)
|
0.05 (4.45)
|
0.05 (5.22)
|
6.06 (16.84)
|
0.71 (1.31)
|
Cmax (mg/L)
|
0.17 (0.15)
|
0.52 (0.15)
|
0.84 (0.63)
|
1.38 (0.45)
|
2.03 (0.85)
|
3.61 (0.47)
|
tmax (h)
|
0.42 (0.36)
|
1 (1.67)
|
1 (0.52)
|
2 (1.86)
|
1 (0.53)
|
6 (3.27)
|
λz (1/h) +
|
2.46 (0.88)
|
0.81 (0.21)
|
1.39 (0.72)
|
0.67 (0.75)
|
0.36 (0.94)
|
0.39 (0.13)
|
t1/2 (h) +
|
0.28 (0.45)
|
0.86 (0.41)
|
0.50 (0.57)
|
1.14 (2.88)
|
1.94 (2.19)
|
1.77 (0.83)
|
AUMClast (mg*h2/L)
|
0.23 (0.56)
|
10.56 (2.82)
|
4.89 (5.74)
|
50.00 (6.43)
|
29.24 (16.62)
|
227.8 (110.7)
|
AUMCinf (mg*h2/L)++
|
0.10 (0.77)
|
10.59 (3.55)
|
4.90 (6.60)
|
52.00 (19.40)
|
21.14 (12.17)
|
235.0 (107.7)
|
AUMC extrap. (%)++
|
0.63 (8.19)
|
0.28 (9.14)
|
0.16 (12.15)
|
0.17 (18.75)
|
7.50 (11.24)
|
3.06 (3.51)
|
MRTlast (h)
|
1.05 (0.55)
|
3.58 (0.49)
|
2.37 (0.49)
|
4.62 (0.77)
|
3.37 (0.66)
|
6.43 (1.26)
|
MRTinf (h)++
|
1.04 (0.62)
|
3.58 (0.71)
|
2.45 (0.59)
|
4.69 (2.19)
|
2.84 (0.73)
|
6.59 (1.16)
|
CL/F (L/h) +
|
5.24 (5.47)
|
0.30 (0.08)
|
0.65 (0.41)
|
0.17 (0.04)
|
0.31 (0.26)
|
0.10 (0.04)
|
Vz/F (L)
+
|
1.86 (2.38)
|
0.41 (0.22)
|
0.62 (0.33)
|
0.26 (0.77)
|
0.86 (0.87)
|
0.36 (0.25)
|